Mosaic Therapeutics

Cambridge, United Kingdom

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

Apr 2025

Corporate Round

Biotechnology Life Science Medical Therapeutics

Top Investors

Cambridge Innovation CapitalInnovate UKSyncona Partners LLPAstex Pharmaceuticals

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mosaic Therapeutics

Who are Mosaic Therapeutics's investors?

Mosaic Therapeutics's investors include Cambridge Innovation Capital, Innovate UK, Syncona Partners LLP, Astex Pharmaceuticals.

Where is Mosaic Therapeutics headquartered?

Mosaic Therapeutics is headquartered in Cambridge, United Kingdom.

What does Mosaic Therapeutics do?

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

What stage is Mosaic Therapeutics at?

Mosaic Therapeutics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Mosaic Therapeutics — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/mosaic-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Mosaic Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/mosaic-therapeutics

Wikipedia (cite web)

{{cite web |title=Mosaic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mosaic-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.